本期内容提示:
1、一大波核心仓位出现建仓机会,优先考虑哪些?
2、又一只有翻倍潜力的成长股临近理想建仓区;
3、$Rxi Pharmaceuticals Corp(PHIO)$ 数据不错,可否追涨?
$恒瑞医药(SH600276)$ $华东医药(SZ000963)$查看全文
Replix锐璞美股2021-03-01 21:16
$Phio Pharmaceuticals(PHIO)$ PHIO PHARMACEUTICALS AND AGONOX, INC. ANNOUNCE COLLABORATION ON CLINICAL DEVELOPMENT OF NOVEL T CELL-BASED CANCER IMMUNOTHERAPIES
Under the terms of the collaboration agreement, AgonOx will receive financial support for the clinical trial from...查看全文
Replix锐璞美股2021-02-18 14:08
$Phio Pharmaceuticals(PHIO)$ 公司增发完毕,看看是否能翻身。
$基因进化ETF-ARK(ARKG)$ $富途控股(FUTU)$查看全文
$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001683168-24-003178 Act: 34 Size: 245 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ ARS Annual Report to Security Holders Accession Number: 0001683168-24-003112 Act: 34 Size: 1 MB 网页链接
$Phio Pharmaceuticals(PHIO)$ DEF 14A Other definitive proxy statements Accession Number: 0001683168-24-003113 Act: 34 Size: 2 MB 网页链接
$Phio Pharmaceuticals(PHIO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001683168-24-003114 Act: 34 Size: 480 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ PRE 14A Other preliminary proxy statements Accession Number: 0001683168-24-002589 Act: 34 Size: 916 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001683168-24-002050 Act: 34 Size: 252 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001683168-24-002021 Act: 34 Size: 5 MB 网页链接
$Phio Pharmaceuticals(PHIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-001324 Size: 5 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-001216 Size: 4 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-001134 Size: 5 KB 网页链接